NCT00566267
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
Not specified
Clinical trial condition
Lipid Metabolism Disorders
Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.
3,309 public trials
330 recruiting studies
Lipid Metabolism Disorders trial results
NCT00267254
- Conditions
- Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +5 more
- Locations
-
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Mobile, Alabama, United States
- Pfizer Investigational Site Mesa, Arizona, United States
- Pfizer Investigational Site Phoenix, Arizona, United States
NCT00542867
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
Not specified
NCT00134498
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
- Locations
-
- Pfizer Investigational Site Anaheim, California, United States
- Pfizer Investigational Site Huntington Beach, California, United States
- Pfizer Investigational Site Los Angeles, California, United States
- Pfizer Investigational Site Orange, California, United States
NCT00454831
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- JSS Medical Research Inc. Westmount, Quebec, Canada
NCT00137462
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- Pfizer Investigational Site Huntsville, Alabama, United States
- Pfizer Investigational Site Union Grove, Alabama, United States
- Pfizer Investigational Site Fresno, California, United States
- Pfizer Investigational Site Los Angeles, California, United States
Completed
Neuropathic Pain and Fabry Disease
NCT00168974
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- Danish Pain Research Center, Aarhus University Hospital Aarhus, Denmark
NCT00134511
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
- Locations
-
- Pfizer Investigational Site Boston, Massachusetts, United States
- Pfizer Investigational Site Chicoutimi, Quebec, Canada
- Pfizer Investigational Site Ste-Foy, Quebec, Canada
- Pfizer Investigational Site Parktown, Johannesburg, South Africa
NCT00405769
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +11 more
- Locations
-
- Chestnut Hill Hospital Philadelphia, Pennsylvania, United States
Completed
Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate
NCT00139061
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- Pfizer Investigational Site Angers, France
- Pfizer Investigational Site Angers, France
- Pfizer Investigational Site Bordeaux Cauderan, France
- Pfizer Investigational Site Briollay, France